Bodenstedt Matthias Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$5.92M

Insider Activity of Bodenstedt Matthias

According to the SEC Form 4 filings, Bodenstedt Matthias, being in a position of

  1. Chief Financial Officer at MoonLake Immunotherapeutics,
    оver the last 12 months, has bought 0 shares, and sold 160870 shares for $3.2M,
    over all time since 2023-12-19, has bought 10870 shares for $98,808, and sold 260870 shares for $9.12M.

Biography of Bodenstedt Matthias

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,198,5017100

Comparison of Insiders on Amount of Buys and Sells

2026-06-22SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
39,120
0.0529%
$22.04$862,205-31.05%
2026-06-18SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
2,794
0.0039%
$19.60$54,762-19.99%
2026-06-17SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
15,082
0.021%
$19.68$296,814-19.49%
2026-05-11SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
13,653
0.0199%
$20.02$273,333-10.32%
2026-04-14SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
2,426
0.0034%
$19.56$47,453-8.52%
2026-04-10SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
1,925
0.0027%
$19.51$37,557-4.23%
2026-04-09SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
85,870
0.1328%
$18.94$1.63M-11.33%
2025-10-08PurchaseMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
10,870
0.0171%
$9.09$98,808+80.99%
2023-12-20SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
5,264
0.0089%
$58.34$307,102-16.41%
2023-12-19SaleMoonLake Immunotherapeutics
MLTX
Chief Financial Officer
94,736
0.1634%
$59.22$5.61M-19.47%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.